Medindia

X

Perrigo Reports Record Third Quarter Revenue, All-Time Record Earnings, and Raises Full Year Adjusted EPS Guidance

Friday, April 30, 2010 General News J E 4
Advertisement

Table III

FY 2010 GUIDANCE AND FY 2009 EPS

RECONCILIATION OF NON-GAAP MEASURES

(unaudited)

Full Year*

Fiscal 2010 Guidance

FY10 reported diluted earnings per share from continuing operations range

$2.42 - $2.47

  Charges associated with inventory step-ups

0.050

  Charge associated with acquired research and development

0.123

  Charges associated with acquisition costs

0.081

  Charges associated with restructuring

0.078

FY10 adjusted diluted earnings per share from continuing operations range

$2.75 - $2.80

Fiscal 2009*

FY09 reported diluted earnings per share from continuing operations

$1.67

  Loss on asset exchange

0.007

  Charges associated with inventory step-ups

0.021

  Fixed asset impairment

0.011

  Write-off of in-process R&D

0.002

  Investment impairment

0.161

FY09 adjusted diluted earnings per share from continuing operations

$1.87

*All information based on continuing operations.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Xoft's Electronic Brachytherapy Hits Milestone Wit...
S
Philips and Orion Health Partner to Deliver on Ent...